Radiation Therapy

The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”. We have been virtualizing various aspects of our lives for many years, but the circumstances of this one has moved almost all of our lives into the virtual realm.

Getty Images

Feature | Radiology Education | September 18, 2020 | By Jef Williams

Extracting Value From Virtual Events

Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”. We have been...

Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020

Study Suggests COVID-19 Pandemic Halted Cancer Care

September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize the...

Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1

News | Treatment Planning | September 15, 2020

Varian's Proton Therapy Treatment Planning Software Clears FDA

September 15, 2020 — Varian announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning...

Sponsored Content

Characteristics nephrologists associate with renal high-risk patients. (n=13)

Characteristics nephrologists associate with renal high-risk patients. (n=13)

Feature | Contrast Media | September 05, 2019

Contrast Media and Renal Risk Mitigation

The global rise in chronic disease has significantly increased demand for diagnostic imaging procedures, and in turn,...

Public health screening guidelines for lung cancer followed by the United States Preventive Services Task Force (USPSTF) and the Center for Medicare and Medicaid Services (CMS) undercount African Americans, contributing to disparities in lung cancer screening and treatment, according to a study published today in the Journal of Thoracic Oncology.

Getty Images

News | Lung Imaging | August 19, 2020

Current Lung Cancer Public Health Screening Guidelines Under Count African Americans

August 19, 2020 — Public health screening guidelines for lung cancer followed by the United States Preventive Services...

A special issue of the Journal of Medical Imaging and Radiation Sciences features stories about the interpersonal skills beyond the technical aspects to care for and guide patients through medical imaging and radiation therapy procedures

Image courtesy of Canon

News | Patient Engagement | August 11, 2020

Patient Experiences in Medical Imaging and Radiation Therapy

August 11, 2020 — "I went into the MRI bracing for the wave of panic I knew would come as soon as I was strapped down...

Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

Image courtesy of Elekta

News | Radiation Therapy | August 06, 2020

Radiotherapy Market to Cross $17 Million Revenue by 2030

August 6, 2020 — Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million...

Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020

Siemens Healthineers Set to Acquire Varian in $16.4B Deal

August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly...

JAMA Oncol. Published online July 30, 2020. doi:10.1001/jamaoncol.2020.2783

Table 1. JAMA Oncol. Published online July 30, 2020. doi:10.1001/jamaoncol.2020.2783

News | Coronavirus (COVID-19) | July 31, 2020

Outcomes in Radiotherapy-treated Patients with Cancer During COVID-19

July 31, 2020 — An article published in JAMA Oncology addresses the delivery of radiotherapy in 209 patients with...

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement to develop new targeted theranostic (diagnostic and therapy) products for a broad range of cancer types.

News | Radiation Oncology | July 29, 2020

Clarity Pharmaceuticals and ImaginAb Collaborate on New Cancer Targets

July 29, 2020 — Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and...

It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer deaths in the UK during the next 12 months, and Zegami, the Oxford University data visualization spin-out which has worked on several projects focused on the detection, diagnosis, or management of cancer, is calling for greater use of technology to speed up the process of diagnosis and treatment.

Getty Images

News | Radiation Oncology | July 29, 2020

Better Use of Technology Needed to Address Coronavirus-fueled Backlog in Cancer Diagnosis

July 29, 2020 — It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer...

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study. http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor

Radiation Therapy Might be a Treatment Option for COVID-19

July 22, 2020 — One of the first studies has been published that looks at the use of radiation therapy to help treat...

A Ludwig Cancer Research study has dissected how radiotherapy alters the behavior of immune cells known as macrophages found in glioblastoma (GBM) tumors and shown how these cells might be reprogrammed with an existing drug to suppress the invariable recurrence of the aggressive brain cancer.

News | Radiation Therapy | July 22, 2020

Study Finds Reprogramming of Immune Cells Enhances Effects of Radiotherapy in Preclinical Models of Brain Cancer

July 22, 2020 — A Ludwig Cancer Research study has dissected how radiotherapy alters the behavior of immune cells known...

World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020

News | ASTRO | July 09, 2020

ASTRO to Host Virtual Annual Meeting in October

July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 62nd Annual Meeting,...

At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review.

Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane

Integrating Artificial Intelligence in Treatment Planning

At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to...

Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.

Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault

Adaptive Therapy Today

Everything has room for improvement, right? Right. When it comes to cancer care, it is no different. Researchers, drug...

Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam

Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.

Proton Therapy Predictions for the Next Decade

The field of proton therapy is continuing to see explosive growth. In the past decade alone, technological advances...

Advanced Radiation Therapy has completed the first AccuBoost Digital installation at Rhode Island Hospital (RIH). This state-of-the-art platform leverages the superior resolution of digital mammography in the delivery of breast radiation therapy.

News | Breast Imaging | July 06, 2020

First AccuBoost Digital Installation for Radiation Treatment of Breast Cancer

July 6, 2020 — Advanced Radiation Therapy has completed the first AccuBoost Digital installation at Rhode Island...

‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›